These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3039783)

  • 21. Proliferation of vascular smooth muscle cells in glioblastoma multiforme.
    Takeuchi H; Hashimoto N; Kitai R; Kubota T; Kikuta K
    J Neurosurg; 2010 Aug; 113(2):218-24. PubMed ID: 19929197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative activity of early gastric cancer measured by in vitro and in vivo bromodeoxyuridine labeling.
    Kamata T; Yonemura Y; Sugiyama K; Ooyama S; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
    Cancer; 1989 Oct; 64(8):1665-8. PubMed ID: 2790680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.
    Kuhn SA; Martin M; Brodhun M; Kratzsch T; Hanisch UK; Haberl H
    Neurol Res; 2014 Aug; 36(8):709-21. PubMed ID: 24620969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocytochemical detection of S-phase cells in normal and neoplastic cervical epithelium by anti-BrdU monoclonal antibody.
    Fukuda K; Iwasaka T; Hachisuga T; Sugimori H; Tsugitomi H; Mutoh F
    Anal Quant Cytol Histol; 1990 Apr; 12(2):135-8. PubMed ID: 2350389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implications of the bromodeoxyuridine labeling index of human gliomas.
    Hoshino T; Prados M; Wilson CB; Cho KG; Lee KS; Davis RL
    J Neurosurg; 1989 Sep; 71(3):335-41. PubMed ID: 2549222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of proliferative activities in human brain tumor specimens: a comparison of three methods.
    Morimura T; Kitz K; Stein H; Budka H
    J Neurooncol; 1991 Feb; 10(1):1-11. PubMed ID: 2022970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence.
    Lee KS; Hoshino T; Rodriguez LA; Bederson J; Davis RL; Wilson CB
    Acta Neuropathol; 1990; 80(3):311-7. PubMed ID: 2399811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A correlative study of in vivo and in vitro labeling index using bromodeoxyuridine in human brain tumors.
    Kharbanda K; Dinda AK; Sarkar C; Karak AK; Dhir R; Mathur M; Roy S
    J Neurooncol; 1995; 23(3):185-90. PubMed ID: 7673980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling.
    Hoshino T; Ahn D; Prados MD; Lamborn K; Wilson CB
    Int J Cancer; 1993 Feb; 53(4):550-5. PubMed ID: 8382191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of chemically induced cell proliferation in rodent liver and kidney: a comparison of 5-bromo-2'-deoxyuridine and [3H]thymidine administered by injection or osmotic pump.
    Eldridge SR; Tilbury LF; Goldsworthy TL; Butterworth BE
    Carcinogenesis; 1990 Dec; 11(12):2245-51. PubMed ID: 2265476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
    Lee KS; Yang WI
    Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas.
    Schröder R; Feisel KD; Ernestus RI
    J Neurooncol; 2002 Jan; 56(2):127-32. PubMed ID: 11995813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative morphology of human glioblastoma multiforme microvessels: structural basis of blood-brain barrier defect.
    Coomber BL; Stewart PA; Hayakawa K; Farrell CL; Del Maestro RF
    J Neurooncol; 1987; 5(4):299-307. PubMed ID: 2831312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between glioblastoma stem-like cells and tumor vascularization.
    He H; Niu CS; Li MW
    Oncol Rep; 2012 Jan; 27(1):45-50. PubMed ID: 21971709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
    Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
    J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
    Onda K; Davis RL; Wilson CB; Hoshino T
    Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
    Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
    J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Factors affecting the prognosis of brain tumors].
    Yoshimine T; Hayakawa T; Mogami H
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2022-7. PubMed ID: 2840033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.